Biochemical-molecular markers in unilateral ureteral obstruction

Biocell

Volumn 31, Issue 1, 2007, Pages 1-12

  Manucha, Walter ^a,b,c  

^a UNIVERSIDAD NACIONAL DE CUYO   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^c Centro Universitario   (Argentina)

Author keywords

Angiotensin II; Interstitial fibrosis; Nitric oxide; Oxidative stress; Unilateral ureteral obstruction

Indexed keywords

ANGIOTENSIN II; ATRIAL NATRIURETIC FACTOR; BRADYKININ; CISPLATIN; DEXAMETHASONE; GENTAMICIN; GLUTATHIONE PEROXIDASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; LOSARTAN; MOLECULAR MARKER; NITRIC OXIDE; PROSTACYCLIN; PROSTAGLANDIN E2; REACTIVE OXYGEN METABOLITE; THROMBOXANE A2;

APOPTOSIS; CELL PROLIFERATION; CONGENITAL DISORDER; DRUG MECHANISM; ENZYME ACTIVITY; FIBROSIS; HUMAN; KIDNEY INJURY; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PROGNOSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; URETER OBSTRUCTION;

ADULT; ANGIOTENSIN II; ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BIOLOGICAL MARKERS; CHILD; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; KIDNEY FAILURE, CHRONIC; NITRIC OXIDE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RENIN; URETERAL OBSTRUCTION;

EID: 34248997820     PISSN: 03279545     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (79)

1. Ahn KY, Mohaupt MG, Madsen KM, Kone BC (1994). In situ hybridization localization of mRNA encoding inducible nitric oxide synthase in rat kidney. Am J Physiol. 267(36): F748-F757.
2. Ambs S, Ogunfusika MO, Merriam WG, Bennett WP, Billiar TR, Harris CC (1998). Up-regulation of inducible nitric oxide synthase expression in cancer-prone p53 knockout mice. Proc Natl Acad Sci. USA. 95: 8823-8828.
3. Andreoli SP, McAteer JA (1990). Reactive oxygen molecule-mediated injury in endothelial and renal tubular epithelial cells in vitro. Kidney Int. 38: 785-794.
4. Angel R, Karin M (1991). The role of Jun, Fos, and the AP-1 complexin cell proliferation and transformation. Biochim Biophys Acta. 1071: 129-157.
5. Ardaillou R (1999). Angiotensin II receptors. J Am Soc Nephrol. 10: S30-S39.
6. Bascands JL, Schanstra JP (2006). Obstructive nephropathy: insights from genetically engineered animals. Kidney Int. 68: 925-937.
7. Beierwaltes WH (1995). Selective neuronal nitric oxide synthase inhibition blocks furosemide-stimulated renin secretion in vivo. Am J Physiol. 269: F134-F139.
8. Blackshear JL, Wathen RL (1978). Effects of indomethacin on renal blood flow and renin secretory responses to ureteral occlusion in the dog. Miner Electrol Metab. 1: 271-278.
9. Cachat F, Lange-Sperandio B, Chang AY, Kiley SC, Thornhill BA, Forbes MS, Chevalier RL (2003). Ureteral obstruction in neonatal mice elicits segment-specific tubular cell responses leading to nephron loss. Kidney Int. 63(2): 564-75.
10. Chevalier RL, Thornhill BA, Ariel-Gomez R (1992). EDRF modulates renal hemodynamics during unilateral ureteral obstruction in the rat. Kidney Int. 42: 400-406.
11. De Nuci G, Gryglewski RJ, Warner TD, Vane JR (1988). Receptor-mediated release of endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells is coupled. Proc Natl Acad Sci USA. 85: 2334-2338.
12. Diamond JR, Kees-Folts D, Ding G (1994). Macrophages, monocyte chemoatractant peptide-1 and TGF-B1 in experimental hydronephrosis. Am J Physiol. 266 (Renal Fluid Electrolyte Physiol 35): F926-F933.
13. Diamond JR, Kees-Folts D, Ricardo SD (1995). Early and persistent up-regulated expression of renal cortical osteopontin in experimental hydronephrosis. Am J Pathol. 146: 1455-1466.
14. Docherty N, O'Sullivan O, Healy D, Fitzpatrick J, Watson W (2006). Evidence that inhibition of tubular cell apoptosis protects against renal damage and development of fibrosis following ureteric obstruction. Am J Physiol. Renal 290: 4-13.
15. Farber JL (1992). Biochemistry of the cell death. J Toxicol Pathol. 5: 1-9.
16. Fenoy FJ, Ferrer P, Carbonell L, Garcia-Salom M (1995). Role of nitric oxide on papillary blood flow and pressure natriuresis. Hypertension. 25: 408-414.
17. Fu JY, Masferrer JL, Seibert K, Raz A, Needleman P (1990). The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes. J Biol Chem. 265: 16737-16740.
18. Gadnapaphornchai P, Aisenbrey G, McDonald KM, Burke TJ, Schrier RW (1978). Prostaglandin-mediated hyperemia and renin-mediated hypertension during acute ureteral obstruction. Prostaglandins. 16: 965-971.
19. Gailit J, Colflesh I, Rabiner I (1993). Redistribution and dysfunction of integrins in cultured renal epithelial cells exposed to oxidative stress. Am J Physiol. 264: F149-F157.
20. Gobe G, Axelsen RA (1995). Genesis of renal tubular atrophy in experimental hydronephrosis in the rat. Role of apoptosis. Lab Invest. 56: 273-281.
21. Goligorsky MS, Brodsky SV, Noiri E (2002). Nitric oxide in acute renal failure: NOS versus NOS. Kidney Int. 61: 855-861.
22. +-ATPase by nitric oxide in mouse proximal tubule epithelial cells. J Clin Invest. 95: 2083-2088.
23. Harris KPG, Klahr S, Schreiner G (1993). Obstructive nephropathy: from mechanical disturbance to immune activation? Exp. Nephrol. 1: 198-204.
24. Harris RC, Martinez-Maldonado M (1995). Angiotensin II-mediated renal injury. Miner Electrolyte Metab. 21(4/5): 328-335.
25. Haugen E, Nath KA (1999). The involvement of oxidative stress in the progression of renal injury. Blood Purif. 17(2-3): 58-65.
26. Houglam K, Brenner DA, Chojkier M (1991). D-alpha-tocopherol inhibits collagen alpha 1 gene expression in cultured human fibroblasts. J Clin Invets. 87: 2230-2235.
27. Hwang SJ, Chang JM, Chen HC, Tsai JH, Lai YH (2002). Changes of renal cortical Na-K ATPase activity, protein, and mRNA expression in ureteral obstruction. Kaohsiung J Med Sci. 18(6): 273-80.
28. Ito S (1995). Nitric oxide in the kidney. Curr Opin Nephrol Hypertension. 4: 23-30.
29. Ito K, Chen J, Seshan SV, Kodadadian JJ, Gallagher R, El Chaar M, Vaughan ED Jr, Poppas DP, Felsen D (2005). Dietary arginine supplementation attenuates renal damage after relief of unilateral ureteral obstruction in rats. Kidney Int. 68(2): 515-528.
30. Ito K, Chen J, Asano T, Vaughan ED Jr, Poppas DP, Hayakawa M, Felsen D (2004). Liposome-mediated gene therapy in the kidney. Hum Cell. 17(1): 17-28.
31. Kerr JF, Wyllie AH, Currie AB (1972). Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 26(4): 239-257.
32. King AJ, Brenner BM (1991). Endothelium-derived vasoactive factors and the renal vasculature. Am J Physiol. 260: R653-R662.
33. Klahr S, Harris KPG, Purkerson ML (1988). Effects of obstruction on renal function. Pediatr Nephrol. 2: 34-42.
34. Klotman PE, Smith SR, Volpp BD, Coffman TM, Yarger WE (1986). Thromboxane synthetase inhibition improves function of hydronephrotic rat kidneys. Am J Physiol. 250(19): F282-F287.
35. Korsmeyer SJ, Yin XM, Oltvai ZN (1995). Reactive oxygen species and the regulation of cell death by the Bcl-2 gene family. Biochim Biophys Acta. 1271: 63-66.
36. Larsen CG, Zacharie CO, Oppenheim JJ, Matsushima K (1989). Production of monocyte chemotactic and activating factor (MCAF) by human dermal fibroblasts in response to interleukin-1 or tumor necrosis factor. Biochem Biophys Res Commun. 160: 1403-1408.
37. Maier JA, Hla T, Maciag T (1990). Cyclooxygenase is an immediate-early gene induced by interleukin-1 in human endothelial cells. J Biol Chem. 265: 10805-10808.
38. Manucha W, Oliveros L, Carrizo L, Seltzer A, Vallés P (2004). Losartan modulation on NOS isoforms and COX-2 expression in early renal fibrogenesis in unilateral obstruction. Kidney Int. 65: 2091-2107.
39. Manucha W, Carrizo L, Alvarez S, Vallés P, Oliveros L (2005a). Effect of losartan pretreatment on kidney lipid content after unilateral obstruction in rats. Cel Mol Biol. 51: 539-545.
40. Manucha W, Carrizo L, Ruete C, Molina H, Vallés P (2005b). Angiotensin II type I antagonist on oxidative stress and heat shock protein 70 (HSP 70) expression in obstructive nephropathy. Cel Mol Biol. 51(6): 547-555.
41. Masferrer JL, Seibert K, Zweifel B, Needleman P (1992). Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme. Proc Natl Acad Sci USA. 89: 3917-3921.
42. Matsusaka T, Ichikawa I (1997). Biological functions of angiotensin and its receptors. Annu Rev Physiol. 59: 395-412.
43. 2 and antioxidants have opposite effects on activations of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J. 12: 2005-2015.
44. Miyajima A, Chen J, Poppas D, Darracott Vaughan Jr. E, Felpen D (2001). Role of nitric oxide in renal tubular apoptosis of unilateral ureteral obstruction. Kidney Int. 59: 1290-1303.
45. Modi KS, Morrisey J, Shah SV (1990). Effects of probucol on renal function in rats with bilateral ureteral obtruction. Kidney Int. 38: 843-850.
46. Mohaupt MG, Elzie JL, Ahn KY, Clapp WL, Wilcox CS, Kone BC (1994). Differential expression and induction of mRNA encoding two inducible nitric oxide synthases in rat kidney. Kidny Int. 46: 653-665.
47. Moncada S, Palmer RMJ, Higgs EA (1991). Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev. 43: 109-142.
48. Moridaira K, Morrissey J, Fitzgerald M, Guo G, McCracken R, Tolley T, Klahr S (2003). ACE inhibition increases expression of the ETB receptor in kidneys of mice with unilateral obstruction. Am J Physiol Renal Physiol. 284(1): F209-217.
49. Morrisey JJ, Klahr S (1998). Differential effects of ACE and AT1 receptor inhibition on chemoattractant and adhesion molecule synthesis. Am J Physiol. 274: F580-F586.
50. Morrisey JJ, Klahr S (1997). Enalapril decreases nuclear factor κB activation in the kidney with ureteral obstruction. Kidney Int. 52: 926-933.
51. Morrisey JJ, McCracken R, Kaneto H, Vehaskari M, Montani D, Klahr S (1994). Location of an inducible nitric oxide synthase mRNA in the normal kidney. Kidney Int. 45: 998-1005.
52. Navar LG, Inscho EW, Majid SA, Imig JD, Harrison Bernard LM, Mitchell KD (1996). Paracrine regulation of the renal microcirculation. Physiol Rev. 76: 425-536.
53. Palmer HJ, Paulson KE (1997). Reactive oxygen species and antioxidants in signals transduction and gene expression. Nutrition Rev. 55: 353-361.
54. Parola M, Muraca R, Dianzani I (1992). Vitamin E dietary supplementation inhibits transforming growth factor B1 gene expression in the rat liver. FEBS Lett. 308: 267-270.
55. Pelaez LI, Juncos LA, Stulak JM, Lerman LO, Romero JC (2005). Non-invasive evaluation of bilateral renal regional blood flow and tubular dynamics during acute unilateral ureteral obstruction. Nephrol Dial Transplant. 20(1): 83-88.
56. Pimentel JL, Montero A, Wang S (1995). Sequential changes in renal expression of renin-angiotensin system genes in acute unilateral ureteral obstruction. Kidney Int. 48: 1247-1253.
57. Pimentel JL Jr, Martínez-Maldonado M, Wilcox JN, Wang S, Luo C (1993). Regulation of renin-angiotensin system in unilateral ureteral obstruction. Kidney Int. 44: 390-400.
58. Poli G, Kinter A, Justement JS (1990). Tumor necrosis factor a fuctions in an autocrine manner in induction of human immunodeficiency virus expression. Proc Natl Acad Sci USA. 87: 782-785.
59. Poli G, Parola M (1997). Oxidative damage and fibrogenesis. Free radical Biol Med. 22: 287-305.
60. Raz A, Wyche A, Siegel N, Needleman P (1988). Regulation of fibroblast cyclooxygenase synthesis by interleukin-1. J Biol Chem. 263: 3022-3028.
61. Reyes AA, Porras BH, Chasalow FI, Klahr S (1994). L-Arginine decreases infiltration of the kidney by macrophages in obstructive uropathy and puromycin-induced nephrosis. Kidney Int. 45: 1346-1354.
62. Ricardo SD, Ding G, Eufemio M, Diamond JR (1997). Antioxidant expression in experimental hydronephrosis: role of mechanical stretch and growth factors. Am J Physiol. 272: F789-F798.
63. Ricardo SD, Levinson ME, DeJoseph MR, Diamond JR (1996). Expression of adhesion molecules in rat renal cortex during experimental hydronephrosis. Kidney Int. 50: 2002-2010.
64. Risdon RA, Sloper JC, De Wardener HE (1968). Relationship between renal function and histological changes found in renal biopsy specimens from patients with persistent glomerulonephritis. Lancet. 1: 363-366.
65. Robin BH, Harris KPG, Morrison A, Klahr S, Schreiner GF (1990). Renal cortical release of a specific macrophage chemoattractant in response to ureteral obstruction. Lab Invest. 63: 213-220.
66. Saavedra JM (1992). Brain and pituitary angiotensin. Endocr Rev. 13: 329-379.
67. Schlondorff D (1995). The role of chemokines in the initiation and progression of renal disease. Kidney Int. 47: S44-S47.
68. Sexton PM, Zhuo J, Mendelsohn FAO (1992). Localization and regulation of renal recepters for angiotensin II and atrial natriuretic peptide. Tohoku J Exp Med. 166: 41-56.
69. Shan ZT, Satriano J, Silbiger S, Schlondorff D (1994). Intracellular glutathione influences collagen generation by mesangial cells. Kidney Int. 46: 388-395.
70. Shi Y, Li C, Thomsen K, Jorgensen TM, Knepper MA, Nielsen S, Djurhuus JC, Frokiaer J (2004). Neonatal ureteral obstruction alters expression of renal sodium transporters and aquaporin water channels. Kidney Int. 66(1): 203-215.
71. Springer TA (1990). Adhesion receptors of the immune system. Nature. 346: 425-434.
72. Stadler J, Racic MS, Billiar TR, Curran RD, Mcintyre LA, Georgescu HL, Simmons RL, Evans CH (1991). Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. J Immunol. 147: 3915-3920.
73. Stratta P, Canavese C, Dogliani M, Mazzucco G, Monga G, Vercellone A (1991). The role of Free Radicals in the progression of renal disease. Am J Kidney Dis. XVII, 5 (S 1): 33-37.
74. Thorup C, Persson AE (1994). Inhibition of locally produced nitric oxide resets tubuloglomerular feedback mechanism. Am J Physiol. 267: F606-F611.
75. Truong LD, Petrusevska G, Yang G (1996). Cell apoptosis and proliferation in experimental chronic obstructive nephropathy. Kidney Int. 50: 200-207.
76. +-ATPase activity on unilateral ureteral obstruction: Interaction of endogenous nitric oxide and angiotensin II. Kidney Int. 58: 1641-1651.
77. Vallés P, Merlo V, Berón W, Manucha W (1999). Recovery of distal nephron enzyme activity after release of unilateral ureteral obstruction. J Urol. 161: 641-648.
78. Valles PG, Pascual L, Manucha W, Carrizo L, Ruttler M (2003). Role of endogenous nitric oxide in unilateral ureteropelvic junction obstruction in children. Kidney Int. 63(3): 1104-1115.
79. Yarger WE, Schocken DD, Harris RH (1980). Obstructive nephropathy in the rat: possible roles for the renin-angiotensin system, prostaglandins, and thromboxanes in postobstructive renal function. J Clin Invest. 65: 400-412.